Amygdala Crh Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label | [1]
|----------|----|---------------| [2]
| Cell Ontology (CL) | CL:4072021 | corticotropin-releasing neuron | [3]
| Database | ID | Name | Confidence | [4]
|----------|----|------|------------| [5]
| Cell Ontology | CL:4072021 | corticotropin-releasing neuron | Exact | [6]
Corticotropin-releasing hormone (CRH)-expressing neurons in the amygdala constitute a pivotal population of peptidergic neurons that orchestrate stress responses, fear conditioning, and anxiety-related behaviors. The amygdala, particularly the central amygdala (CeA), contains a dense population of CRH neurons that integrate sensory information about threats and coordinate appropriate behavioral and physiological responses. These neurons play critical roles in neurodegenerative diseases through their modulation of stress pathways, hypothalamic-pituitary-adrenal (HPA) axis function, and emotional memory circuits. [7]
CRH, also known as corticotropin-releasing factor (CRF), is a 41-amino acid peptide hormone that serves as the primary regulator of the stress response. In the amygdala, CRH neurons function as key nodes in fear and anxiety circuits, and their dysfunction contributes to the pathophysiology of multiple neurodegenerative disorders.
Amygdala CRH neurons express a distinctive set of neurochemical markers:
Amygdala CRH neurons exhibit distinctive morphological features:
Characterization of amygdala CRH neurons reveals:
CRH neurons are concentrated in specific amygdala subnuclei:
Inputs to amygdala CRH neurons:
Outputs from amygdala CRH neurons:
Fear conditioning circuit:
Stress response circuit:
Amygdala CRH neurons are significantly affected in Alzheimer's disease:
Pathological changes:
Functional consequences:
Clinical implications:
Therapeutic considerations:
CRH neurons contribute to Parkinson's disease pathophysiology:
Stress vulnerability:
Circuit dysfunction:
Treatment implications:
Frontotemporal dementia:
Huntington's disease:
Amyotrophic lateral sclerosis:
Amygdala CRH activity can be assessed through:
CRH receptor antagonists:
Behavioral interventions:
Pharmacological strategies:
Amygdala CRH neurons integrate with the hypothalamic-pituitary-adrenal axis:
Upstream regulation:
Downstream effects:
The HPA axis operates through negative feedback:
Amygdala CRH neurons are essential for fear learning:
Chronic stress alters CRH neuron function:
Sustained activation
Circuit plasticity
Behavioral manifestations
Corticotropin-Releasing Hormone
Central Amygdala
Basolateral Amygdala
Hypothalamic CRH Neurons
HPA Axis
Stress Responsemechanisms/stress-response-neurodegeneration)
Fear Conditioning
Amygdala Crh Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Amygdala Crh Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sahoo B, et al. CRH and the amygdala: molecular mechanisms of fear and stress. Mol Psychiatry. 2020;25(5):986-1003. 2020. ↩︎
Tye KM, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471(7338):358-362. 2011. ↩︎
Duvarci S, et al. The bed nucleus of the stria terminalis mediates stress-induced anxiety. J Neurosci. 2019;39(45):8920-8931. 2019. ↩︎
Regev L, et al. CRH and the extended amygdala: stress-related behaviors. Handb Exp Pharmacol. 2020;260:123-151. 2020. ↩︎
Rao RP, et al. Stress and the amygdala in neurodegeneration. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110058. 2021. ↩︎
Gafford GM, et al. CRH-dependent mechanisms of fear learning and extinction. Neuropsychopharmacology. 2020;45(9):1501-1512. 2020. ↩︎
Silberman Y, et al. CRH system and amygdala function in stress-related disorders. Biol Psychiatry. 2022;91(8):700-712. 2022. ↩︎